Clinical trials: Resistant Hypertension
Patients, Resistant Hypertension
Safety and Efficacy Study of LHW090 in Resistant Hypertension Patients
The purpose of the present study was to determine whether LHW090 displays the clinical safety and efficacy profile to support further development in patients with resistant hypertension.
- Trial name
- NCT02515331
- Testing
- LHW090
- Where
- 16 sites in United States, Denmark and 4 more
- Volunteers
- 64 people
- Sponsor
- Novartis Pharmaceuticals
Pulmonary Hypertension
Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease (The SATURN Study).
This study is a prospective, randomized, double-blind, study of H01 (Hymecromone) in adults with pulmonary hypertension (PH). The primary objective of this study is to evaluate the safety and tolerability of oral H01 and the…
- Trial name
- SATURN (NCT05128929)
- Testing
- Hymecromone (H01)
- Where
- United States
- Volunteers
- 17 people
- Sponsor
- Stanford University
Metabolic Syndrome, Hypertension
Oral Nitrite in Adults With Metabolic Syndrome and Hypertension
This research study is being conducted to examine the effects of daily inorganic nitrite treatment on the cardiometabolic and hormonal disturbances observed in overweight/obese adults with the metabolic syndrome and high blood…
- Trial name
- ONTX (NCT01681810)
- Testing
- 14Nitrogen Sodium Nitrite
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Gladwin, Mark, MD
Hypertension
Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation
The purpose of this study is to test whether abatacept, a drug approved by the Food and Drug Administration to treat rheumatoid arthritis, may help blood pressure medications to work better.
- Trial name
- NCT02232880
- Testing
- Abatacept
- Where
- United States
- Volunteers
- 1 people
- Sponsor
- Vanderbilt University Medical Center